Development · 11 Sep 2026
2 publishers have reported this development. Each act of reporting is below, cited.
Indoco Remedies' manufacturing facility at Plant I in Goa successfully completed an inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from September 7, 2026, to September 9, 2026, with no critical or major observations.
Indoco Remedies announced that the UK Medicines and Healthcare Products Regulatory Agency (UKMHRA) inspected its solid dosages manufacturing facility in Goa from September 7 to September 9, 2026, and the inspection concluded with no critical or major observations.
The UK Medicines and Healthcare products Regulatory Agency inspected Indoco Remedies' Plant I facility in Goa from September 7 to September 9 and concluded with no critical or major observations.
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.